Atacicept is a medication being studied for treating various autoimmune diseases that affect the kidneys (glomerular diseases). It works by targeting specific proteins in the immune system that are involved in the inflammatory process. This medication aims to reduce protein in the urine (proteinuria) and help control the immune system’s attack on kidney tissues.

Multiple Autoimmune Glomerular Disease – A group of kidney disorders where the immune system attacks and damages the glomeruli, the tiny filtering units in the kidneys. The condition typically involves inflammation of the glomeruli, leading to protein leakage into urine (proteinuria). The disease can affect both kidneys simultaneously and often progresses gradually over time. Different forms of this condition can involve various immune system components attacking different parts of the kidney’s filtering system. The damage to glomeruli can cause problems with the kidney’s ability to filter waste products from the blood.

IgA Nephropathy – A kidney disease that occurs when immunoglobulin A (IgA) builds up in the kidneys, causing inflammation that damages kidney tissues. The disease progresses slowly and affects the kidney’s filtering units called glomeruli. It causes protein and blood to leak into the urine. The condition often develops during early adulthood.

Membranous Nephropathy – A kidney disease characterized by thickening of the glomerular basement membrane due to immune deposits. The condition causes damage to the filtering membranes in the kidneys, leading to significant protein loss in the urine. It develops gradually and primarily affects adults. The disease can result in swelling in various body parts due to protein loss.